News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Myeloma Paper of the Day, May 10th, suggested by Robert Orlowski
May 10, 2024, 16:40

Myeloma Paper of the Day, May 10th, suggested by Robert Orlowski

Robert Orlowski, Director of Myeloma Section at MD Anderson Cancer Center, shared on X:

“Myeloma Paper of the Day: Prospective biomarker study finds preexisting cytopenias and hyperferritinemia predict long duration of post-CAR T-cell cytopenias, which may relate to immune remodeling with shift in CAR-negative T-cell subsets following therapy.”

Source: Robert Orlowski/X

Changes in T-cell subsets, preexisting cytopenias and hyperferritinaemia correlate with cytopenias after BCMA targeted CAR T-cell therapy in relapsed/refractory multiple myeloma: Results from a prospective comprehensive biomarker study

Authors: Xiang Zhou, Vivien Wagner, Lukas Scheller, Emilia Stanojkovska, Christine Riedhammer, Xianghui Xiao, Maximilian Johannes Steinhardt, Cornelia Vogt, Silvia Nerreter, Florian Eisele, Mara John, Umair Munawar, Sofie-Katrin Kadel, Julia Mersi, Anna Ruckdeschel, Sven Schimanski, Larissa Haertle, Johannes Waldschmidt, Seungbin Han, Max Topp, Johannes Duell, Hermann Einsele, Angela Riedel, K. Martin Kortüm, and Leo Rasche.

Myeloma Paper of the Day

Other insights by Robert Orlowski on OncoDaily.

Angela Riedel Anna Ruckdeschel cancer Christine Riedhammer Cornelia Vogt Emilia Stanojkovska Florian Eisele Hermann Einsele Johannes Duell Johannes Waldschmidt Julia Mersi K. Martin Kortüm Larissa Haertle Leo Rasche Lukas Scheller Mara John Max Topp Maximilian Johannes Steinhardt MD Anderson Cancer Center Myeloma Paper of the Day OncoDaily Oncology relapsed/refractory multiple myeloma Robert Orlowski Seungbin Han Silvia Nerreter Sofie-Katrin Kadel Sven Schimanski Umair Munawar Vivien Wagner Xiang Zhou Xianghui Xiao
Special Coverage
Opinion
Nov 13, 2024, 17:14
Share your experiences of life with a kidney cancer diagnosis - Action Kidney Cancer
Blog
Nov 13, 2024, 16:51
The 11th edition of Richi Entrepreneurs has officially kicked off
Blog
Nov 13, 2024, 16:49
Dégi László Csaba: Transforming Cancer Care Together
Blog
Nov 13, 2024, 16:45
Jun Gong: The best awards are patient awards
Blog
Nov 13, 2024, 16:39
Bami Adenipekun: How being impacted by breast cancer for over 3 decades shapes the work that I do
Insight
Nov 13, 2024, 16:25
A clear picture of the ground reality
Insight
Nov 13, 2024, 16:23
Make your mark in Oncology research with JCO Oncology Advances - ASCO
Blog
Nov 13, 2024, 16:08
Evolving role of Radiation in early stage NSCLC by Dr. Annalisa Nardone
Insight
Nov 13, 2024, 16:02
Exploring New Avenues in Breast Cancer Treatment - The Babak Lab
Insight
Nov 13, 2024, 16:00
Role of antibody drug conjugates in the treatment of patients with breast cancer brain metastases
Blog
Nov 13, 2024, 15:56
Awareness campaigns have helped Increase Lung Cancer Screening Rates - IASLC
Blog
Nov 13, 2024, 15:56
Jennifer Ivanovich: Thrilled to see the announcement of the new ESMO Rare Cancers journal